Senti Biosciences Inc (SNTI) — Financial Flexibility Index
Senti Biosciences Inc (SNTI) has a Financial Flexibility Index of -0.21x as of September 2025. Free cash flow of $-9.45 Million (operating CF $-9.45 Million minus capex $0.00) represents 0% of total liabilities ($44.56 Million). Also explore Senti Biosciences Inc equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Senti Biosciences Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Senti Biosciences Inc across 6 annual periods. Check strategic asset allocation of Senti Biosciences Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Senti Biosciences Inc (2019–2024)
Year-by-year free cash flow to debt coverage for Senti Biosciences Inc. For the full company profile including market capitalisation, see SNTI company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.57x | $-41.37 Million | $-41.40 Million | $72.19 Million | ▲ +25.3% |
| 2023 | -0.77x | $-40.36 Million | $-52.40 Million | $52.57 Million | ▼ -734.3% |
| 2022 | 0.12x | $6.48 Million | $-34.90 Million | $53.53 Million | ▲ +115.1% |
| 2021 | -0.80x | $-29.09 Million | $-34.63 Million | $36.33 Million | ▼ -272.6% |
| 2020 | -0.21x | $-23.01 Million | $-24.17 Million | $107.06 Million | ▲ +76.5% |
| 2019 | -0.92x | $-16.38 Million | $-18.38 Million | $17.88 Million | — |